214 related articles for article (PubMed ID: 10225476)
1. Troglitazone and metformin, but not glibenclamide, decrease blood pressure in Otsuka Long Evans Tokushima Fatty rats.
Kosegawa I; Chen S; Awata T; Negishi K; Katayama S
Clin Exp Hypertens; 1999 Apr; 21(3):199-211. PubMed ID: 10225476
[TBL] [Abstract][Full Text] [Related]
2. Troglitazone improves GLUT4 expression in adipose tissue in an animal model of obese type 2 diabetes mellitus.
Furuta M; Yano Y; Gabazza EC; Araki-Sasaki R; Tanaka T; Katsuki A; Hori Y; Nakatani K; Sumida Y; Adachi Y
Diabetes Res Clin Pract; 2002 Jun; 56(3):159-71. PubMed ID: 11947963
[TBL] [Abstract][Full Text] [Related]
3. Troglitazone stimulates pancreatic growth in congenitally CCK-A receptor-deficient OLETF rats.
Jia DM; Fukumitsu KI; Tabaru A; Akiyama T; Otsuki M
Am J Physiol Regul Integr Comp Physiol; 2001 May; 280(5):R1332-40. PubMed ID: 11294751
[TBL] [Abstract][Full Text] [Related]
4. A comparison of the hypotensive and hypoglycaemic actions of an angiotensin converting enzyme inhibitor, an AT1a antagonist and troglitazone.
Chen S; Noguchi Y; Izumida T; Tatebe J; Katayama S
J Hypertens; 1996 Nov; 14(11):1325-30. PubMed ID: 8934361
[TBL] [Abstract][Full Text] [Related]
5. Troglitazone improves blood flow by inhibiting neointimal formation after balloon injury in Otsuka Long-Evans Tokushima fatty rats.
Min KM; Park SW; Cho KY; Song MS; Kim DK; Park GS; Lee MK
Metabolism; 2002 Aug; 51(8):998-1002. PubMed ID: 12145772
[TBL] [Abstract][Full Text] [Related]
6. Troglitazone prevents fatty changes of the liver in obese diabetic rats.
Jia DM; Tabaru A; Akiyama T; Abe S; Otsuki M
J Gastroenterol Hepatol; 2000 Oct; 15(10):1183-91. PubMed ID: 11106100
[TBL] [Abstract][Full Text] [Related]
7. Troglitazone ameliorates abnormal activity of protein tyrosine phosphatase in adipose tissues of Otsuka Long-Evans Tokushima Fatty rats.
Tagami S; Honda T; Yoshimura H; Homma H; Ohno K; Ide H; Sakaue S; Kawakami Y
Tohoku J Exp Med; 2002 Jul; 197(3):169-81. PubMed ID: 12365558
[TBL] [Abstract][Full Text] [Related]
8. Troglitazone prevents and reverses dyslipidemia, insulin secretory defects, and histologic abnormalities in a rat model of naturally occurring obese diabetes.
Jia DM; Tabaru A; Nakamura H; Fukumitsu KI; Akiyama T; Otsuki M
Metabolism; 2000 Sep; 49(9):1167-75. PubMed ID: 11016899
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the metabolic effects of metformin and troglitazone on fructose-induced insulin resistance in male Sprague-Dawley rats.
Chen CC; Wang HJ; Shih HC; Sheen LY; Chang CT; Chen RH; Wang TY
J Formos Med Assoc; 2001 Mar; 100(3):176-80. PubMed ID: 11393112
[TBL] [Abstract][Full Text] [Related]
10. Glucose transporter levels in a male spontaneous non-insulin-dependent diabetes mellitus rat of the Otsuka Long-Evans Tokushima Fatty strain.
Toide K; Man ZW; Asahi Y; Sato T; Nakayama N; Noma Y; Oka Y; Shima K
Diabetes Res Clin Pract; 1997 Dec; 38(3):151-60. PubMed ID: 9483380
[TBL] [Abstract][Full Text] [Related]
11. Troglitazone: a review of its use in the management of type 2 diabetes mellitus.
Plosker GL; Faulds D
Drugs; 1999 Mar; 57(3):409-38. PubMed ID: 10193691
[TBL] [Abstract][Full Text] [Related]
12. Effects of troglitazone on collagen accumulation and distensibility of aortic wall in prestage of non-insulin-dependent diabetes mellitus of Otsuka Long-Evans Tokushima Fatty rats.
Mizushige K; Noma T; Yao L; Yu Y; Kiyomoto H; Hosomi N; Fukui T; Kimura S; Abe Y; Matsuo H
J Cardiovasc Pharmacol; 2000 Jan; 35(1):150-5. PubMed ID: 10630746
[TBL] [Abstract][Full Text] [Related]
13. Beneficial effect of troglitazone, an insulin-sensitizing antidiabetic agent, on coronary circulation in patients with non-insulin-dependent diabetes mellitus.
Sekiya M; Suzuki J; Watanabe K; Funada J; Otani T; Akutsu H
Jpn Circ J; 2001 Jun; 65(6):487-90. PubMed ID: 11407727
[TBL] [Abstract][Full Text] [Related]
14. Metformin decreases blood pressure and obesity in OLETF rats via improvement of insulin resistance.
Kosegawa I; Katayama S; Kikuchi C; Kashiwabara H; Negishi K; Ishii J; Inukai K; Oka Y
Hypertens Res; 1996 Mar; 19(1):37-41. PubMed ID: 8829822
[TBL] [Abstract][Full Text] [Related]
15. Troglitazone improves endothelial function and augments renal klotho mRNA expression in Otsuka Long-Evans Tokushima Fatty (OLETF) rats with multiple atherogenic risk factors.
Yamagishi T; Saito Y; Nakamura T; Takeda S; Kanai H; Sumino H; Kuro-o M; Nabeshima Y; Kurabayashi M; Nagai R
Hypertens Res; 2001 Nov; 24(6):705-9. PubMed ID: 11768731
[TBL] [Abstract][Full Text] [Related]
16. A comparison of troglitazone and metformin on insulin requirements in euglycemic intensively insulin-treated type 2 diabetic patients.
Yu JG; Kruszynska YT; Mulford MI; Olefsky JM
Diabetes; 1999 Dec; 48(12):2414-21. PubMed ID: 10580431
[TBL] [Abstract][Full Text] [Related]
17. Troglitazone stimulates pancreatic growth in normal rats.
Jia DM; Otsuki M
Pancreas; 2002 Apr; 24(3):303-12. PubMed ID: 11893940
[TBL] [Abstract][Full Text] [Related]
18. Beneficial insulin-sensitizing and vascular effects of S15261 in the insulin-resistant JCR:LA-cp rat.
Russell JC; Ravel D; Pégorier JP; Delrat P; Jochemsen R; O'Brien SF; Kelly SE; Davidge ST; Brindley DN
J Pharmacol Exp Ther; 2000 Nov; 295(2):753-60. PubMed ID: 11046115
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus.
Inzucchi SE; Maggs DG; Spollett GR; Page SL; Rife FS; Walton V; Shulman GI
N Engl J Med; 1998 Mar; 338(13):867-72. PubMed ID: 9516221
[TBL] [Abstract][Full Text] [Related]
20. Troglitazone improves insulin-stimulated glucose utilization associated with an increased muscle glycogen content in obese Zucker rats.
Oshida Y; Kako M; Nakai N; Shimomura Y; Li L; Sato J; Ohsawa I; Sato Y
Endocr J; 1999 Oct; 46(5):723-30. PubMed ID: 10670760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
